Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- METI to Investigate Needs for R&D Promotion Taxation System
October 30, 2006
- SELF-MEDICATION NEWS IN BRIEF
October 23, 2006
- JPA to Launch Data Sheet Database in Early December
October 23, 2006
- SURVEY 2 articles
October 23, 2006
- Shionogi, Hokkaido Univ. Jointly Create Drug Discovery Center
October 23, 2006
- Baxter Announces Results of PI/II Clinical Trial of Cell-Based H5N1 Vaccine
October 23, 2006
- Pulmicort Respules to Popularize Inhalant Steroids in Japan: AstraZeneca
October 23, 2006
- REGULATORY NEWS IN BRIEF -2-
October 23, 2006
- Taiho: Sales Up 2.0%, Strong Growth of TS-1, Global Business Props Up Overall Performance
October 23, 2006
- New Mechanism Leading to Development of Anticancer Drugs Discovered by AIST Researchers
October 23, 2006
- Hisamitsu: Sales Up 9.9%, Net Profits Up 10.3%
October 23, 2006
- Understanding of Public Indispensable to Utilize PGx: Prof. Tsuya
October 23, 2006
- Expansion of GE Drug Market Pushes Up Nichi-iko's Sales, Profits
October 23, 2006
- R&D NEWS IN BRIEF
October 23, 2006
- BUSINESS NEWS IN BRIEF
October 23, 2006
- NEW PRODUCTS
October 23, 2006
- SEMINAR
October 23, 2006
- 21st Scientific Meeting of the International Society of Hypertension
October 23, 2006
- NEW PRODUCTS
October 23, 2006
- Iressa as a Drug for 21st Century Personalized Medicine
October 23, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…